Company intelligence / Profile preview

Phibro Animal Health

Ownership: Public · PAHC
Employees: ~2300
Development stage: Other

Overview

Phibro Animal Health markets a broad portfolio of commercialized animal health products including medicated feed additives, antimicrobials, nutritional supplements/minerals and vaccines for food-producing animals. The company has a global presence with over $1 billion in annual sales as of fiscal year ended June 2024. Recent acquisitions have expanded its product range further into medicated feed additives and water-soluble therapeutics[1][10].

Therapeutic areas: Metabolic DisordersInfectious Diseases
Modalities: Small moleculeVaccineProteinMineral product
Industry: Veterinary

Partnerships

Recent acquisition from Zoetis indicates transactional relationships with major industry players[10].

Financials

Market cap: $1.4B
Total revenue: $1.5B
Enterprise value: $2.1B

Beyond the preview

Go deeper on Phibro Animal Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phibro Animal Health.